Large-scale epidemiological data on cardiovascular diseases and diabetes in migrant and ethnic minority groups in Europe
Large-scale epidemiological data on cardiovascular diseases and diabetes in migrant and ethnic minority groups in Europe
复制标题
DOI：
10.1093/eurpub/ckp073
复制
发表时间：
2009-10-01
影响因子：
4.4
通讯作者：
Bhopal, Raj S.
中科院分区：
文献类型：
--
作者：
Rafnsson, Snorri B.;Bhopal, Raj S.
背景：心血管疾病（CVD）和糖尿病的种族差异数据反映了不同文化、社会和宗教因素的影响，对于提供疾病病因学线索以及指导公共卫生干预和医疗保健资源具有重要意义。方法：通过欧洲公共卫生研究人员网络以及对书目数据库和互联网站点的搜索，我们确定了当前欧盟国家冠心病（CHD）、中风和糖尿病死亡率和发病率的种族相关数据的可用性和特征；英国四个国家的数据分别进行了评估。结果：总共 25 个国家拥有一个或多个相关数据集（总共 72 个）；然而，三分之二（n = 47）的数据源仅来自八个北欧和西欧国家。对于一些国家，无法确定数据。 24 个国家都有与种族相关的国家死亡登记册。出生国家是最常见的种族指标。目前，关于流动人口和少数民族人群中冠心病、中风和糖尿病发病率的数据很少；在国家之间和国家内部，种族以及疾病结果的定义和衡量方式都存在重大差异，这限制了数据的可比性。结论：可靠的常规数据是国家和欧盟层面循证公共卫生政策的关键。欧盟国家在评估移民和少数民族人口的需求和规划医疗保健干预措施方面基础相对薄弱。整个欧盟缺乏有关心血管疾病和糖尿病的种族相关数据，这一问题亟待解决。
Background: Data on differences by ethnicity in cardiovascular diseases (CVDs) and diabetes, reflecting the influence of diverse cultural, social and religious factors, are important to providing clues to disease aetiology and directing public health interventions and health care resources. Methods: Through a network of European public health researchers and searches of bibliographic databases and internet sites, we determined the availability and characteristics of ethnically relevant data on mortality and morbidity from coronary heart disease (CHD), stroke and diabetes, in current European Union countries; data from the four countries comprising the UK were assessed separately. Results: In total, 25 countries had one or more relevant data sets (72 in total); however, two-thirds (n = 47) of the data sources came from only eight Nordic and Western European countries. For several countries, no data could be identified. Ethnically relevant, national death registers were available in 24 countries. Country of birth was the most common indicator of ethnicity. Data on CHD, stroke and diabetes morbidity among migrant and ethnic minority populations are currently scarce; both between and within countries, there are important differences in how ethnicity as well as disease outcomes are defined and measured which limits data comparability. Conclusion: Reliable routine data are key to evidence-based public health policies at both national and EU level. EU countries have a relatively weak base for assessing needs and planning health care interventions for its migrant and ethnic minority populations. The lack of ethnically relevant data on CVD and diabetes across the EU needs to be addressed urgently.